NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
5
As on 27th Jun 2025 004310 STOCK Price closed @ 3415.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4010.06 & Strong Sell for SHORT-TERM with Stoploss of 3882.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3435.00 Change Price %
High 3450.00 1 Day -25.00 -0.73
Low 3380.00 1 Week -85.00 -2.43
Close 3415.00 1 Month -35.00 -1.01
Volume 105580 1 Year -355.00 -9.42
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
009070 5550.00 14.67%
009070 5550.00 14.67%
004140 2930.00 2.27%
004140 2930.00 2.27%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
039830 13190.00 29.95%
039830 13190.00 29.95%
020760 981.00 29.93%
020760 981.00 29.93%
168490 159.00 29.27%
168490 159.00 29.27%
152550 383.00 19.69%
152550 383.00 19.69%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
001745 3600.00 -46.27%
001745 3600.00 -46.27%
016385 10450.00 -37.05%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE3549.89
RESISTANCE3506.63
RESISTANCE3479.89
RESISTANCE3453.15
SUPPORT3376.85
SUPPORT3350.11
SUPPORT3323.37
SUPPORT3280.11
 
004310 Forecast July 2025
4th UP Forecast3916.02
3rd UP Forecast3755.34
2nd UP Forecast3656.02
1st UP Forecast3556.7
1st DOWN Forecast3273.3
2nd DOWN Forecast3173.98
3rd DOWN Forecast3074.66
4th DOWN Forecast2913.98
 
004310 Weekly Forecast
4th UP Forecast4127.99
3rd UP Forecast3899.33
2nd UP Forecast3757.99
1st UP Forecast3616.65
1st DOWN Forecast3213.35
2nd DOWN Forecast3072.01
3rd DOWN Forecast2930.67
4th DOWN Forecast2702.01
 
004310 Forecast2025
4th UP Forecast10400.4
3rd UP Forecast8160.13
2nd UP Forecast6775.38
1st UP Forecast5390.63
1st DOWN Forecast1439.38
2nd DOWN Forecast54.63
3rd DOWN Forecast-1330.13
4th DOWN Forecast-3570.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service